Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pharvaris (PHVS)
NASDAQ:PHVS
Pharvaris (PHVS) Stock Price & Analysis
59 Followers
PHVS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.93 - $33.00
Previous Close$20.15
Volume38.24K
Average Volume (3M)110.88K
Market Cap
$864.53M
Enterprise Value$408.17M
Total Cash (Recent Filing)€391.23M
Total Debt (Recent Filing)€238.91K
Price to Earnings (P/E)-7.4
Beta-1.55
Next Earnings
May 07, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.71
Shares Outstanding52,290,212
10 Day Avg. Volume69,023
30 Day Avg. Volume110,879
Standard Deviation0.76
R-Squared0.04
Alpha0.12
Financial Highlights & Ratios
Price to Book (P/B)9.16
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$33.60Price Target Upside58.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Pharvaris News
Ownership Overview
0.00%
Insiders
7.13% Mutual Funds
83.41% Other Institutional Investors
9.45% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PHVS FAQ
What was Pharvaris’s price range in the past 12 months?
Pharvaris lowest stock price was $7.93 and its highest was $33.00 in the past 12 months.
What is Pharvaris’s market cap?
Currently, no data Available
When is Pharvaris’s upcoming earnings report date?
Pharvaris’s upcoming earnings report date is May 07, 2024 which is in 12 days.
How were Pharvaris’s earnings last quarter?
Pharvaris released its earnings results on Apr 10, 2024. The company reported -$0.786 earnings per share for the quarter, missing the consensus estimate of -$0.587 by -$0.199.
Is Pharvaris overvalued?
According to Wall Street analysts Pharvaris’s price is currently Undervalued.
Does Pharvaris pay dividends?
Pharvaris does not currently pay dividends.
What is Pharvaris’s EPS estimate?
Pharvaris’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharvaris have?
Pharvaris has 40,856,823 shares outstanding.
What happened to Pharvaris’s price movement after its last earnings report?
Pharvaris reported an EPS of -$0.786 in its last earnings report, missing expectations of -$0.587. Following the earnings report the stock price went up 0.18%.
Which hedge fund is a major shareholder of Pharvaris?
Among the largest hedge funds holding Pharvaris’s share is Viking Global Investors LP. It holds Pharvaris’s shares valued at 103M.
---
Pharvaris Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$33.60 (58.79% Upside)
$33.60 (58.79% Upside)
Hedge Fund Trend
Increased
By 1.3M Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
131.60%
12-Months-Change
Fundamentals
Return on Equity
-37.36%
Trailing 12-Months
Asset Growth
146.03%
Trailing 12-Months
Company Description
Pharvaris
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.
---
PHVS Stock 12 Months Forecast
Average Price Target
$33.60
▲(58.79% Upside)
Technical Analysis
Best Analysts Covering PHVS
1 Year
1 Year Success Rate
11/16 ratings generated profit
1 Year Average Return
+85.04%
reiterated a buy rating 14 days ago
Copying Jonathan Wolleben's trades and holding each position for 1 Year would result in 68.75% of your transactions generating a profit, with an average return of +85.04% per trade.
---